NMR Spectroscopy: Application to Metabolic Research

The aim of this chapter is to demonstrate the considerable clinical potential of NMR spectroscopy. In reviewing the course of imaging and spectroscopy over the past decade one sees that imaging has moved from visualisation of the internal structure of various fruits to high definition neurological and body imaging, where pixel sizes (× 0.3 mm2) approach those obtainable in high resolution CT. However, the clinical superiority of NMR imaging in identifying pathological information is controversial: conversely, the interpretation of NMR spectroscopy, especially 31P, is well understood. Few in vivo clinical studies have been performed, principally due to the low availability of large magnets of suitable field strength and the formidable difficulties of defining precise volumes within a patient from which spectra may be taken. In reviewing the field of NMR spectroscopy it will be shown that these obstacles can be overcome and that much of the groundwork on animal studies may be readily transferred to the clinical environment. Many clinical spectroscopy systems have come into operation over the past year and a large increase in human studies is expected.

[1]  D. Gadian,et al.  Proton NMR studies of muscle metabolites in vivo , 1985 .

[2]  M. Civan,et al.  Intracellular pH of perfused single frog skin: combined 19F- and 31P-NMR analysis. , 1984, The American journal of physiology.

[3]  D. Wilkie,et al.  CLINICAL USE OF NUCLEAR MAGNETIC RESONANCE IN THE INVESTIGATION OF MYOPATHY , 1982, The Lancet.

[4]  A. N. Stevens,et al.  NMR Studies of metabolites in living tissue , 1982 .

[5]  G. Radda,et al.  Clinical aspects on 31P NMR spectroscopy. , 1984, British medical bulletin.

[6]  S K Hilal,et al.  In vivo NMR imaging of tissue sodium in the intact cat before and after acute cerebral stroke. , 1983, AJNR. American journal of neuroradiology.

[7]  D. Gadian,et al.  Mapping of metabolites in whole animals by 31P NMR using surface coils , 1980, Nature.

[8]  H. Sostman,et al.  NMR in cancer. I. High resolution spectroscopy of tumors. , 1984, Magnetic resonance imaging.

[9]  C. Tanaka,et al.  In vivo measurement of energy metabolism and the concomitant monitoring of electroencephalogram in experimental cerebral ischemia , 1984, Brain Research.

[10]  D. R. Wilkie,et al.  31P-NMR STUDIES OF A HUMAN TUMOUR IN SITU , 1983, The Lancet.

[11]  L. Medaris A tectonic mélange of foreign eclogites and ultramafites in West Norway , 1980, Nature.

[12]  G. Radda,et al.  Analysis of rat heart in vivo by phosphorus nuclear magnetic resonance. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Bendall,et al.  Depth and refocusing pulses designed for multipulse NMR with surface coils , 1983 .

[14]  D. Gadian,et al.  31P NMR examination of two patients with NADH-CoQ reductase deficiency , 1982, Nature.

[15]  D. Gadian,et al.  EXAMINATION OF A MYOPATHY BY PHOSPHORUS NUCLEAR MAGNETIC RESONANCE , 1981, The Lancet.

[16]  P. J. Hore,et al.  Solvent suppression in Fourier transform nuclear magnetic resonance , 1983 .

[17]  J. Ackerman,et al.  Phosphorus-31 NMR of rat brain in vivo with bloodless perfluorocarbon perfused rat. , 1984, Biochemical and biophysical research communications.

[18]  R. Shulman,et al.  In vivo carbon-13 nuclear magnetic resonance studies of heart metabolism. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[19]  B Chance,et al.  Noninvasive, nondestructive approaches to cell bioenergetics. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Griffiths,et al.  Detection of glycogen in a glycogen storage disease by 13C nuclear magnetic resonance , 1982, FEBS letters.

[21]  J R Griffiths,et al.  31P-NMR investigation of solid tumours in the living rat , 1981, Bioscience reports.

[22]  B. Chance,et al.  31P nuclear magnetic resonance spectroscopic investigation of human neuroblastoma in situ. , 1985, The New England journal of medicine.

[23]  D. Gadian,et al.  Effects of fructose on the energy metabolism and acid-base status of the perfused starved-rat liver. A 31phosphorus nuclear magnetic resonance study. , 1980, The Biochemical journal.

[24]  R. Shulman,et al.  Natural abundance Carbon-13 nuclear magnetic resonance spectroscopy of liver and adipose tissue of the living rat. , 1983, Biochemistry.

[25]  Raj K. Gupta,et al.  Direct observation of resolved resonances from intra- and extracellular sodium-23 ions in NMR studies of intact cells and tissues using dysprosium(III)tripolyphosphate as paramagnetic shift reagent☆ , 1982 .

[26]  B Chance,et al.  Mitochondrial regulation of phosphocreatine/inorganic phosphate ratios in exercising human muscle: a gated 31P NMR study. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[27]  T. Grist,et al.  Resonators for in Vivo 31P NMR at 1.5 T , 1985 .

[28]  D. Wilkie,et al.  SURFACE COIL NMR SPECTROSCOPY OF BRAIN , 1984, The Lancet.

[29]  D. Gadian,et al.  Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study. , 1983, Molecular biology & medicine.

[30]  E Proctor,et al.  Neurometabolic effects of an inborn error of amino acid metabolism demonstrated in vivo by 1H NMR , 1986, Magnetic resonance in medicine.

[31]  G K Radda,et al.  Examination of a case of suspected McArdle's syndrome by 31P nuclear magnetic resonance. , 1981, The New England journal of medicine.

[32]  Non invasive investigation of cerebral metabolism in newborn infants by 31P NMR spectroscopy. , 1983 .

[33]  R G Shulman,et al.  1H-Observe/13C-decouple spectroscopic measurements of lactate and glutamate in the rat brain in vivo. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Griffiths,et al.  5-fluorouracil metabolism monitored in vivo by 19F NMR. , 1984, British Journal of Cancer.

[35]  D. Arnold,et al.  EXCESSIVE INTRACELLULAR ACIDOSIS OF SKELETAL MUSCLE ON EXERCISE IN A PATIENT WITH A POST-VIRAL EXHAUSTION/FATIGUE SYNDROME A 31P Nuclear Magnetic Resonance Study , 1984, The Lancet.

[36]  E. Shoubridge,et al.  31P NMR saturation transfer measurements of the steady state rates of creatine kinase and ATP synthetase in the rat brain , 1982, FEBS letters.

[37]  A. Costello,et al.  NON-INVASIVE INVESTIGATION OF CEREBRAL METABOLISM IN NEWBORN INFANTS BY PHOSPHORUS NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY , 1983, The Lancet.

[38]  R. Shulman,et al.  In vivo 31P‐NMR studies of myocardial high energy phosphate metabolism during anoxia and recovery , 1983, FEBS letters.

[39]  J. Griffiths,et al.  VIP enhances TRH‐stimulated prolactin secretion of pituitary tumours , 1984, FEBS letters.

[40]  P. Bottomley,et al.  Assessment of pharmacological treatment of myocardial infarction by phosphorus-31 NMR with surface coils. , 1981, Science.

[41]  T. Ng,et al.  In vivo31P NMR study of the metabolism of murine mammary 16/C adenocarcinoma and its response to chemotherapy, x-radiation, and hyperthermia , 1983 .

[42]  S Müller,et al.  Volume-selective excitation. A novel approach to topical NMR , 1984 .

[43]  R. Hesketh,et al.  Intracellular calcium measurements by 19F NMR of fluorine-labeled chelators. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Paul A. Bottomley,et al.  Slice-interleaved depth-resolved surface-coil spectroscopy (SLIT DRESS) for rapid 31P NMR in Vivo , 1985 .

[45]  G. Radda,et al.  A method for localizing high‐resolution NMR spectra from human subjects , 1985, Magnetic resonance in medicine.

[46]  Roger J. Ordidge,et al.  Image selected in-vivo spectroscopy (ISIS) , 1985 .

[47]  R. Shulman,et al.  Detection of cerebral lactate in vivo during hypoxemia by 1H NMR at relatively low field strengths (1.9 T). , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Roger J. Ordidge,et al.  Image-selected in Vivo spectroscopy (ISIS). A new technique for spatially selective nmr spectroscopy , 1986 .

[49]  R G Shulman,et al.  Cerebral metabolic studies in vivo by 31P NMR. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Weisfeldt,et al.  Phosphorus nuclear magnetic resonance studies of heart physiology , 1978 .

[51]  Jerry D. Glickson,et al.  31P NMR spectroscopy of in vivo tumors , 1982 .

[52]  Brian Ross,et al.  MONITORING RESPONSE TO CHEMOTHERAPY OF INTACT HUMAN TUMOURS BY 31P NUCLEAR MAGNETIC RESONANCE , 1984, The Lancet.

[53]  R. Shulman,et al.  Structure and metabolism of mammalian liver glycogen monitored by carbon-13 nuclear magnetic resonance. , 1983, Biochemistry.

[54]  P A Bottomley,et al.  Noninvasive detection and monitoring of regional myocardial ischemia in situ using depth-resolved 31P NMR spectroscopy. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[55]  T. Koeze,et al.  In vivo nuclear magnetic resonance spectroscopy of a transplanted brain tumour. , 1984, British Journal of Cancer.

[56]  J. Schenck,et al.  NMR IMAGING/SPECTROSCOPY SYSTEM TO STUDY BOTH ANATOMY AND METABOLISM , 1983, The Lancet.

[57]  R. Balaban,et al.  In vivo flux between phosphocreatine and adenosine triphosphate determined by two-dimensional phosphorous NMR. , 1983, The Journal of biological chemistry.

[58]  N. Minshew,et al.  ANATOMICAL CONSIDERATIONS FOR INTERPRETING TOPICAL 31P-NMR , 1983, The Lancet.

[59]  S K Hilal,et al.  In vivo MR spectroscopic imaging with P-31. Work in progress. , 1984, Radiology.